These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26553795)

  • 1. Effective Use of Mass Spectrometry in the Clinical Laboratory.
    Jannetto PJ; Fitzgerald RL
    Clin Chem; 2016 Jan; 62(1):92-8. PubMed ID: 26553795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometry in the clinical laboratory. A short journey through the contribution to the scientific literature by
    Rankin-Turner S; Heaney LM
    Clin Chem Lab Med; 2023 Apr; 61(5):873-879. PubMed ID: 36282951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry in newborn and metabolic screening: historical perspective and future directions.
    Chace DH
    J Mass Spectrom; 2009 Feb; 44(2):163-70. PubMed ID: 19034889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The art of measuring steroids: Principles and practice of current hormonal steroid analysis.
    Wudy SA; Schuler G; Sánchez-Guijo A; Hartmann MF
    J Steroid Biochem Mol Biol; 2018 May; 179():88-103. PubMed ID: 28962971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of confiscated black market drugs using chromatographic and mass spectrometric approaches.
    Thevis M; Schrader Y; Thomas A; Sigmund G; Geyer H; Schänzer W
    J Anal Toxicol; 2008 Apr; 32(3):232-40. PubMed ID: 18397575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ion mobility spectrometry/mass spectrometry of some prescription and illicit drugs.
    Lawrence AH
    Anal Chem; 1986 May; 58(6):1269-72. PubMed ID: 3717581
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new tool for biological study: hair analysis. Value in medical practice].
    Goullé JP; Kintz P
    Rev Med Interne; 1996; 17(10):826-35. PubMed ID: 8976976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National academy of clinical biochemistry laboratory medicine practice guidelines: follow-up testing for metabolic disease identified by expanded newborn screening using tandem mass spectrometry; executive summary.
    Dietzen DJ; Rinaldo P; Whitley RJ; Rhead WJ; Hannon WH; Garg UC; Lo SF; Bennett MJ
    Clin Chem; 2009 Sep; 55(9):1615-26. PubMed ID: 19574465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent applications of mass spectrometry in pharmaceutical research.
    Horváth G
    Prog Drug Res; 1974; 18():399-473. PubMed ID: 4453610
    [No Abstract]   [Full Text] [Related]  

  • 11. The evolution of methods for urinary steroid metabolomics in clinical investigations particularly in childhood.
    Honour JW; Conway E; Hodkinson R; Lam F
    J Steroid Biochem Mol Biol; 2018 Jul; 181():28-51. PubMed ID: 29481855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The scope of mass spectrometry in clinical chemistry.
    Lawson AM
    Clin Chem; 1975 Jun; 21(7):803-24. PubMed ID: 1132130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gas chromatography-mass spectrometry in the study of illegal mescaline/dimethyltryptamine--laboratory findings].
    Gielsdorf W; Schubert K; Allin K
    Arch Kriminol; 1980; 166(1-2):21-32. PubMed ID: 6778403
    [No Abstract]   [Full Text] [Related]  

  • 14. Liquid chromatography tandem mass spectrometry in the clinical laboratory.
    Adaway JE; Keevil BG; Owen LJ
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):18-38. PubMed ID: 25313226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LC–MS endocrine drug analysis: Thermo Fisher’s free solutions library.
    Payne T
    Bioanalysis; 2011 Dec; 3(24):2707. PubMed ID: 22292159
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of dangerous drugs by mass spectrometry.
    Law NC; Aandahl V; Fales HM; Milne GW
    Clin Chim Acta; 1971 Apr; 32(2):221-8. PubMed ID: 4399316
    [No Abstract]   [Full Text] [Related]  

  • 17. Pilot proficiency testing study for second tier congenital adrenal hyperplasia newborn screening.
    De Jesús VR; Simms DA; Schiffer J; Kennedy M; Mei JV; Hannon WH
    Clin Chim Acta; 2010 Nov; 411(21-22):1684-7. PubMed ID: 20619255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded newborn screening by mass spectrometry: New tests, future perspectives.
    Ombrone D; Giocaliere E; Forni G; Malvagia S; la Marca G
    Mass Spectrom Rev; 2016; 35(1):71-84. PubMed ID: 25952022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent instrumental progress in mass spectrometry: advancing resolution, accuracy, and speed of drug detection.
    Thevis M; Volmer DA
    Drug Test Anal; 2012; 4(3-4):242-5. PubMed ID: 22374710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Mass Spectrometry-Achieving Prominence in Laboratory Medicine.
    Annesley TM; Cooks RG; Herold DA; Hoofnagle AN
    Clin Chem; 2016 Jan; 62(1):1-3. PubMed ID: 26719566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.